Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pasireotide for Hypoglycemia after Gastric Bypass
NCT03514576Phase 4Unknown
- Sponsor
- Zealand University Hospital
- Start
- Jun 2018
- Primary completion
- Aug 2018
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of pasireotide LAR in Postprandial hyperinsulinemic hypoglycemia (PHH), sponsored by Zealand University Hospital. Status: unknown.
02
Drugs
pasireotide LAR
03
Conditions
Postprandial hyperinsulinemic hypoglycemia (PHH)
Beyond the preview
Go deeper on NCT03514576.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03514576.